Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Takayoshi Oikawa"'
Autor:
Masashi Ninomiya, Mio Tsuruoka, Jun Inoue, Atsushi Hiraoka, Tomoaki Iwata, Akitoshi Sano, Kosuke Sato, Masazumi Onuki, Satoko Sawahashi, Hidekatsu Kuroda, Takayoshi Oikawa, Masashi Fujita, Kazumichi Abe, Tomohiro Katsumi, Wataru Sato, Go Igarashi, Chikara Iino, Tetsu Endo, Nobukazu Tanabe, Hiroshi Numao, Katsunori Iijima, Takayuki Matsumoto, Hiromasa Ohira, Yoshiyuki Ueno, Atsushi Masamune
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract It is difficult to determine whether an individual therapy contributes to the elongation of survival because of the difficulty of organizing clinical research in patients who receive multiple treatments in HCC. We aimed to establish a new mo
Externí odkaz:
https://doaj.org/article/11d8cecf2b5d4cb8a1e0c970a7172a60
Autor:
Keisuke Kakisaka, Nobuaki Nakayama, Kotaro Kumagai, Takuro Hisanaga, Takayuki Kondo, Toru Setsu, Shunsuke Sato, Yohei Kooka, Kei Endo, Yuichi Yoshida, Takayoshi Oikawa, Hidekatsu Kuroda, Akio Miyasaka, Ryuzo Abe, Taka-aki Nakada, Yoshihiro Ikura, Kenichi Harada, Takuya Genda, Shuji Terai, Naoya Kato, Taro Takami, Akio Ido, Satoshi Mochida, Takayuki Matsumoto, Atsushi Tanaka
Publikováno v:
Gastro Hep Advances, Vol 2, Iss 4, Pp 497-504 (2023)
Background and Aims: Acute liver injury (ALI) due to autoimmune hepatitis (AIH) can be treated by immunosuppression. In contrast, idiosyncratic drug-induced liver injury (DILI) had a poor prognosis. DILI thus needs to be distinguished from non-DILI.
Externí odkaz:
https://doaj.org/article/41e7930ab9084fc1bab5aaa463fc1040
Autor:
Masashi Fujita, Kazumichi Abe, Hidekatsu Kuroda, Takayoshi Oikawa, Masashi Ninomiya, Atsushi Masamune, Kazuo Okumoto, Tomohiro Katsumi, Wataru Sato, Katsunori Iijima, Tetsu Endo, Shinsaku Fukuda, Nobukazu Tanabe, Hiroshi Numao, Yasuhiro Takikawa, Yoshiyuki Ueno, Hiromasa Ohira
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Sarcopenia is associated with poor prognosis of patients with hepatocellular carcinoma (HCC). We investigated the association of skeletal muscle volume (SMV) and its change in HCC patients taking lenvatinib. In 130 HCC patients, psoas mass i
Externí odkaz:
https://doaj.org/article/90a8f11b5c724eb5964b2dfc5f11d103
Autor:
Keisuke Kakisaka, Takuro Sato, Yasunori Wada, Ai Ito, Hisashi Eto, Hiroaki Abe, Jo Kanazawa, Kenji Yusa, Yohei Kooka, Kei Endo, Yuichi Yoshida, Takayoshi Oikawa, Hidekatsu Kuroda, Akio Miyasaka, Manami Akasaka, Takayuki Matsumoto
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 32, Iss , Pp 100898- (2022)
Externí odkaz:
https://doaj.org/article/653252260b4845e693333d2bb8c67a40
Autor:
Kei Endo, Hidekatsu Kuroda, Takayoshi Oikawa, Yuma Ito, Tamami Abe, Youhei Kooka, Keisuke Kakisaka, Akio Miyasaka, Tamotsu Sugai, Takayuki Matsumoto
Publikováno v:
Liver Cancer (2022)
Externí odkaz:
https://doaj.org/article/f6285cda65754bb4afc2e187c5c55558
Autor:
Hidekatsu Kuroda, Takayoshi Oikawa, Masashi Ninomiya, Masashi Fujita, Kazumichi Abe, Kazuo Okumoto, Tomohiro Katsumi, Wataru Sato, Go Igarashi, Chikara Iino, Tetsu Endo, Nobukazu Tanabe, Hiroshi Numao, Shinsaku Fukuda, Katsunori Iijima, Atsushi Masamune, Hiromasa Ohira, Yoshiyuki Ueno, Yasuhiro Takikawa
Publikováno v:
Liver Cancer (2022)
Objective: There is limited information regarding the benefits of Lenvatinib-transcatheter arterial chemoembolization (LEN-TACE) sequential therapy for unresectable hepatocellular carcinoma (u-HCC). We compared the efficacy and safety of LEN-TACE seq
Externí odkaz:
https://doaj.org/article/6a9871223fd94efcbd3d56089fd44d0f
Autor:
Hidekatsu Kuroda, Tomoaki Nagasawa, Yudai Fujiwara, Hiroki Sato, Tamami Abe, Yohei Kooka, Kei Endo, Takayoshi Oikawa, Kei Sawara, Yasuhiro Takikawa
Publikováno v:
Cancers, Vol 13, Iss 6, p 1295 (2021)
There is limited information regarding the oncological benefits of microwave ablation using ThermosphereTM technology for hepatocellular carcinoma. This study compared the overall survival and recurrence-free survival outcomes among patients with hep
Externí odkaz:
https://doaj.org/article/1c0f683db39144b7ac6128041ca8f7f5
Autor:
Kei Endo, Hidekatsu Kuroda, Jo Kanazawa, Takuro Sato, Yudai Fujiwara, Tamami Abe, Hiroki Sato, Youhei Kooka, Takayoshi Oikawa, Kei Sawara, Yasuhiro Takikawa
Publikováno v:
Cancers, Vol 12, Iss 8, p 2146 (2020)
Although sarcopenia is characterized by a loss of muscle strength and skeletal muscle mass, few studies have evaluated the effect of muscle strength on hepatocellular carcinoma (HCC) patients. We evaluated the impact of sarcopenia-related factors (gr
Externí odkaz:
https://doaj.org/article/825ec3b980574111a4bd34f2a5ee7512
Autor:
Kotaro Kishimoto, Keisuke Kakisaka, Tamami Abe, Asami Ito, Kenji Yusa, Akiko Suzuki, Kei Endo, Yuichi Yoshida, Takayoshi Oikawa, Akio Miyasaka, Ayaka Sato, Masao Nishiya, Naoki Yanagawa, Hidekatsu Kuroda, Takayuki Matsumoto
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 14, p2011-2014, 4p
Autor:
Akio Miyasaka, Yuichi Yoshida, Akiko Suzuki, Kei Endo, Keisuke Kakisaka, Takayoshi Oikawa, Takaya Abe, Wataru Obara, Takayuki Matsumoto
Publikováno v:
Therapeutic Apheresis and Dialysis.